Higher blood pressure was predicted by higher posterior circulation involvement and bilateral disease.
Neurological and neuropsychological examinations were performed to assess intellectual disabilities, and biological assays were performed on collected CSF and plasma.
Updates were published for prenatal diagnostic testing for genetic disorders and screening for fetal aneuploidy.
Mouse models of Down syndrome showed up to 3 times the number of RCAN1 compared to normal chromosomes.
The collaborative research effort hopes to identify biomarkers that can be applied to other populations.
Researchers stress that people will still need to confirm the diagnosis with invasive diagnostic tests.
Neurology Advisor Articles
- Multiple System Atrophy: A Common Form of Atypical Parkinsonism
- Migraine Treatment in the ED: Overcoming Our Penchant for Opioids
- Erenumab as a Therapy for Hard to Treat Episodic Migraine
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy
- Reduced Survival for Patients With Idiopathic Parkinsonism
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Biomarkers of Alzheimer Disease Observed in Down Syndrome
- Short Segment Sensory Nerve Stimulation Offers Potential Diagnostic Value for Ulnar Neuropathy
- Incidence of Guillain-Barré Syndrome Linked With Recent Bone, Digestive Organ Surgery
- Online Tool Helps Patients With Advance Care Planning
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds